Cargando…

Spirometric Lung Functions in Type 2 Diabetes Mellitus: A Hospital-Based Study

Objective This cross-sectional case-control study was conducted with the aim to analyze spirometric lung functions in type 2 diabetes mellitus (T2DM) patients and to correlate the spirometric dysfunction with (a) duration of diabetes, b) metabolic control of diabetes, and c) microvascular complicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Ashish, Sharma, Anupriya, Chauhan, Rakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257798/
https://www.ncbi.nlm.nih.gov/pubmed/37309345
http://dx.doi.org/10.7759/cureus.38919
_version_ 1785057367641030656
author Sharma, Ashish
Sharma, Anupriya
Chauhan, Rakesh
author_facet Sharma, Ashish
Sharma, Anupriya
Chauhan, Rakesh
author_sort Sharma, Ashish
collection PubMed
description Objective This cross-sectional case-control study was conducted with the aim to analyze spirometric lung functions in type 2 diabetes mellitus (T2DM) patients and to correlate the spirometric dysfunction with (a) duration of diabetes, b) metabolic control of diabetes, and c) microvascular complications of diabetes. Methods Pulmonary function tests (PFTs) were performed in 50 T2DM patients and 50 normal healthy controls aged <80 years by using an electronic spirometer. The PFTs recorded were as follows: forced vital capacity (FVC), forced expiratory volume in one second (FEV1), FEV1%, forced expiratory flow 25 (FEF25), forced expiratory flow 25-75 (FEF25-75), and peak expiratory flow rate (PEFR). The glycated hemoglobin (HbA1c) of all the patients was measured by affinity chromatography using the NycoCard HbA1C kit. The assessment of diabetic microvascular complications was performed as follows: peripheral neuropathy was done using Michigan Neuropathy Screening Instrument (MNSI), diabetic retinopathy using fundus examination, and diabetic nephropathy using solid phase/sandwich-format/immunometric assay using NycoCard U-albumin kit. PFTs of diabetic patients and controls were compared by applying an independent sample t-test. The correlation between FVC and FEV1, and HbA1c and duration of illness in diabetic patients was analyzed by applying the Pearson coefficient. Results  The cases had low FVC (103.82 ±24.43 vs. 116.08 ±13.66), FEV1 (101.36 ±24.23 vs. 110.26 ±14.39), FEV1% (97.56 ±8.64 vs. 103.84 ±5.06), PEFR (101.52 ±27.18 vs. 116.96 ±14.96), and FEF 25-75 (73.56 ±29.19 vs. 98.40 ±14.45) compared to controls, and the difference was statistically significant. A significant negative correlation was found between spirometry parameters and duration of illness as well as HbA1c. Spirometric lung dysfunction also negatively correlated with microvascular complications of diabetes. Among various microvascular complications, retinopathy correlated best with various spirometric parameters. Conclusion Based on our findings, T2DM patients had a significant decrease in their spirometric indices. The pattern of spirometric dysfunction was suggestive of "mixed ventilatory dysfunction". The study results highlight the need to include PFTs in the periodic check-up as part of the comprehensive management of diabetic patients. Hence, pulmonary function should be included in the periodic comprehensive diabetic check for the holistic management of these patients.
format Online
Article
Text
id pubmed-10257798
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-102577982023-06-12 Spirometric Lung Functions in Type 2 Diabetes Mellitus: A Hospital-Based Study Sharma, Ashish Sharma, Anupriya Chauhan, Rakesh Cureus Internal Medicine Objective This cross-sectional case-control study was conducted with the aim to analyze spirometric lung functions in type 2 diabetes mellitus (T2DM) patients and to correlate the spirometric dysfunction with (a) duration of diabetes, b) metabolic control of diabetes, and c) microvascular complications of diabetes. Methods Pulmonary function tests (PFTs) were performed in 50 T2DM patients and 50 normal healthy controls aged <80 years by using an electronic spirometer. The PFTs recorded were as follows: forced vital capacity (FVC), forced expiratory volume in one second (FEV1), FEV1%, forced expiratory flow 25 (FEF25), forced expiratory flow 25-75 (FEF25-75), and peak expiratory flow rate (PEFR). The glycated hemoglobin (HbA1c) of all the patients was measured by affinity chromatography using the NycoCard HbA1C kit. The assessment of diabetic microvascular complications was performed as follows: peripheral neuropathy was done using Michigan Neuropathy Screening Instrument (MNSI), diabetic retinopathy using fundus examination, and diabetic nephropathy using solid phase/sandwich-format/immunometric assay using NycoCard U-albumin kit. PFTs of diabetic patients and controls were compared by applying an independent sample t-test. The correlation between FVC and FEV1, and HbA1c and duration of illness in diabetic patients was analyzed by applying the Pearson coefficient. Results  The cases had low FVC (103.82 ±24.43 vs. 116.08 ±13.66), FEV1 (101.36 ±24.23 vs. 110.26 ±14.39), FEV1% (97.56 ±8.64 vs. 103.84 ±5.06), PEFR (101.52 ±27.18 vs. 116.96 ±14.96), and FEF 25-75 (73.56 ±29.19 vs. 98.40 ±14.45) compared to controls, and the difference was statistically significant. A significant negative correlation was found between spirometry parameters and duration of illness as well as HbA1c. Spirometric lung dysfunction also negatively correlated with microvascular complications of diabetes. Among various microvascular complications, retinopathy correlated best with various spirometric parameters. Conclusion Based on our findings, T2DM patients had a significant decrease in their spirometric indices. The pattern of spirometric dysfunction was suggestive of "mixed ventilatory dysfunction". The study results highlight the need to include PFTs in the periodic check-up as part of the comprehensive management of diabetic patients. Hence, pulmonary function should be included in the periodic comprehensive diabetic check for the holistic management of these patients. Cureus 2023-05-12 /pmc/articles/PMC10257798/ /pubmed/37309345 http://dx.doi.org/10.7759/cureus.38919 Text en Copyright © 2023, Sharma et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Sharma, Ashish
Sharma, Anupriya
Chauhan, Rakesh
Spirometric Lung Functions in Type 2 Diabetes Mellitus: A Hospital-Based Study
title Spirometric Lung Functions in Type 2 Diabetes Mellitus: A Hospital-Based Study
title_full Spirometric Lung Functions in Type 2 Diabetes Mellitus: A Hospital-Based Study
title_fullStr Spirometric Lung Functions in Type 2 Diabetes Mellitus: A Hospital-Based Study
title_full_unstemmed Spirometric Lung Functions in Type 2 Diabetes Mellitus: A Hospital-Based Study
title_short Spirometric Lung Functions in Type 2 Diabetes Mellitus: A Hospital-Based Study
title_sort spirometric lung functions in type 2 diabetes mellitus: a hospital-based study
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257798/
https://www.ncbi.nlm.nih.gov/pubmed/37309345
http://dx.doi.org/10.7759/cureus.38919
work_keys_str_mv AT sharmaashish spirometriclungfunctionsintype2diabetesmellitusahospitalbasedstudy
AT sharmaanupriya spirometriclungfunctionsintype2diabetesmellitusahospitalbasedstudy
AT chauhanrakesh spirometriclungfunctionsintype2diabetesmellitusahospitalbasedstudy